Advanced Biomed Inc Accounts Payable
Advanced Biomed Inc (ADVB) had Accounts Payable of $377.26 thousand as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-05-15
- 2026-03-31: Accounts Payable, Current $377.26K.
- 2025-12-31: Accounts Payable, Current $369.29K.
- 2025-09-30: Accounts Payable, Current $641.59K.
- 2025-06-30: Accounts Payable, Current $358.24K; Accounts Payable, Current as first filed $632.70K.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-03-31 | $377.26K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $369.29K 10-Q · filed 2026-02-13 | |
| 2025-09-30 | $641.59K 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $358.24K 10-Q · filed 2026-05-15 | $632.70K 10-K · filed 2025-10-08 |
| 2025-03-31 | $618.52K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $617.87K 10-Q · filed 2025-04-15 | |
| 2024-06-30 | $620.48K 10-K · filed 2025-10-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |